Sarepta to pause gene therapy Elevidys shipments in US – Reuters

  1. Sarepta to pause gene therapy Elevidys shipments in US  Reuters
  2. Third death from a Sarepta gene therapy  BioCentury
  3. Sarepta Therapeutics Announces Strategic Restructuring and Pipeline Prioritization Plan to Maintain Long-term, Sustainable Growth and Provides Update on ELEVIDYS Label  Sarepta Therapeutics
  4. Post-Hoc Live: What’s next with Sarepta and its showdown with the FDA?  Endpoints News
  5. MHE Week in Review – International AIDS Society (IAS) 2025 Meeting Coverage  Managed Healthcare Executive

Continue Reading